In addition, Metsera today announced the exercise in full by the underwriters of their option to purchase 2,291,666 additional shares, at the initial public offering price of $18.00 per share ...
Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...
In addition, Metsera today announced the exercise in full by the underwriters of their option to purchase 2,291,666 additional shares, at the initial public offering price of $18.00 per share, and the ...
We recently published a list of 10 Stocks With At Least $10 Million In Insider Spending Recently. In this article, we are ...
In other recent news, Metsera Inc has made significant strides with its initial public offering (IPO), which opened 42% higher than its offering price. The company initially set its IPO at $18.00 ...
Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...
In other recent news, Metsera Inc has made significant strides with its initial public offering (IPO), which opened 42% higher than its offering price. The company initially set its IPO at $18.00 per ...
Insider Monkey on MSN12d
Metsera (MTSR): Among Stocks Insiders Spent The Most Money On RecentlyOn February 3, three insiders purchased a total of around $94.22 million worth of Metsera shares during the company’s initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback